GET IN TOUCH
Please lodge your grievances with SEBI at https://scores.gov.in
As per PMLA Amendment, linking of Aadhaar with Demat/Trading account is mandatory. All the existing clients shall link their Aadhaar by 31st March 2018. In case the account is not linked within the aforesaid time limit, it will be blocked till Aadhaar Submission.
As per NSDL Circular No: NSDL/POLICY/2017/0022 dated 17th April 2017, all Individual and entity accounts opened from 1st July 2014 to 31st August 2015 has to submit Foreign Account Tax Compliance Act (FATCA) self-declaration (CLICK HERE TO DOWNLOAD ATTACHED FATCA) till 30th April 2017. All the Account Holders who have opened the Demat Account from the period 1st July 2014 to 31st August 2015 are informed to submit the FATCA self declaration to their nearest DP. In case self certification are not provided till 30th April 2017, the Accounts would be blocked.
As per SEBI Letter on collection of Email Ids and Bank Account Details and with Reference to NSDL Circular No: NSDL/POLICY/2017/0009 dated 28th February 2017, it has been observed that Email Ids, Bank Account Details, Mobile Number, SMS Alert of many existing clients are not linked to their Demat Accounts or updated with their latest Bank Account thereby forcing companies to issue printed cheques/warrants and non-receipt of SMS alerts to the client. It is requested to all existing Account Holders to contact their nearest DP for updation of mentioned details in their Demat Accounts.
All existing Individual Demat Account Holders are advised to submit Aadhaar number along with copy of Aadhaar Card to their nearest FSC's.
Ganga Pharmaceuticals Ltd |
---|
Registered Office: Gangatat Dhanvantri Marg, Gopcharpada Virar (E), Palghar - 401305, Maharashtra |
Phone: 91-250-6098333/444 |
Email: ayurvedganga@gmail.com |
Website: www.ayurvedganga.com |
Public offer of 10,24,000 equity shares of face value of Rs. 10/- each (Equity shares) of Ganga Pharmaceuticals Limited (The issure) for cash at a price Rs. 15/- per equity share (Including a share premium of Rs. 5/- per equity share) (Issue price) aggregating to Rs. 1.54 crores. The issue Constitutes 25.21% of the post issue paid up equity share capital of the company. This Being a fixed price, as per sub clause (4) of regulation 43 of The Sebi (ICDR) Regulations, 2009 as amended (The SEBI Regulations), The Issue of 10,24,000 equity shares, not less than 50% shall be avalable to retail individual investors and the remanining to individual applicants other than retail investors and other investor including corporate bodies or institutions irrespective of the number of shares applied for. If the retail individual investor category is entitled to more than 50% on proporationate basis, They shall be allotted that higher percentage. The face value of the equity shares is Rs. 10 each. The Issue price of equity shares Rs. 15/- each and The issue Price is 1.5 times of the face value. |
Issue | Money Payable On | ||
---|---|---|---|
Opens On | Closes On | Application | Allotment |
29-Jan-2016 | 11-Feb-2016 | ₹ 15.00 | ₹ 0.00 |
Minimum Application for shares in Nos : 8000 Further Multiples of : 8000 | ||
---|---|---|
(₹)Cr. | Lead Managers to the Issue | |
Project Cost | 1.54 | First Overseas Capital Ltd |
Project Financed through Current Offer | 1.54 | |
Post Issue Equity Share Capital | 4.06 | |
Issue Price | ₹15.00 |
Projects |
---|
Deployment of production capacity |
Marketing and Brand Building |
General Corporate Purpose |
Promoted By |
---|
Bharat B Sharma |
Srijana B Sharma |
Listing At |
---|
BSE - SME |
Registrar to the Issue |
---|
KFin Techologies Ltd |
INDIAN INDICES
84,544.31 1,359.51 (1.63%)
25,790.95 375.15 (1.48%)
GLOBAL INDICES
83.95 -0.07 (-0.08%)
18,013.98 440.68 (2.51%)
18258.57 245.41(1.36%)